% Expired Patents = 14.3

EPO Patents = 1

Trademarks = 5

Forward Citations = 12

Loading Chart...

7 inventors (with patents filed for the assignee):

Matthew Merrill Carter (6 out of 15 patents)

Paul Daniel Donohoue (6 out of 47 patents)

Daniela Roth (1 out of 2 patents)

4. Ranjan Batra (1 out of 2 patents)

5. Daniel A Knowland (1 out of 1 patent)

6. Rachel A Adams (1 out of 1 patent)

7. Rea Lardelli Markmiller (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12037588 - Compositions and methods comprising engineered short nuclear RNA (snRNA) (2024-07-16),

2. 11939606 - CRISPR-associated (Cas) protein (2024-03-26),

3. 11932883 - CRISPR-associated (Cas) protein (2024-03-19),

4. 11293011 - CRISPR-associated (CAS) protein (2022-04-05),

5. 11028381 - CRISPR-associated (Cas) protein (2021-06-08),

6. 10889808 - CRISPR-associated (CAS) protein (2021-01-12),

7. 10876101 - CRISPR-associated (Cas) protein (2020-12-29),

Locanabio is a biotechnology company focused on developing precision genetic medicines for neurological disorders. The company utilizes their proprietary delivery platform to create targeted therapies that aim to treat a broad range of neurodegenerative diseases. Locanabio is dedicated to advancing the field of gene therapy to improve the lives of patients with unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

7 Patents

#702 in San Diego, CA

#9,481 in California

#39,855 in US

San Diego, CA, United States of America

Locanabio, Inc.